On the other hand, the controversial and dual role of MMP2 emerges from its association with improved overall survival rates in melanoma patients with a higher mutation burden due to its activity of freeing extracellular matrix (ECM) structural protein mutants adjacent to MMP2‐sensitive sites. This evidence concerns the gene MMP2 and melanoma.